Population
McA-RH7777 cells
Comparison
Stable expression of recombinant apolipoprotein… vs Lipid-poor conditions or cells without the…
Design
Preclinical
Authors
Loading...
May influence VLDL production in lipid-rich states; leaves open therapeutic implications for apoC-III inhibition pending in vivo confirmation.
Expression of apoC-III enhances hepatic TAG-rich VLDL assembly and secretion under lipid-rich conditions, highlighting its intracellular role in lipid metabolism.
Sundaram et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: